Researcher profile

Emilio Ros

Former director of the Lipid Clinic and Senior Consultant, Endocrinology & Nutrition Service, Hospital Clínic, University of Barcelona. C. Villarroel, 170 - 08036 Barcelona. MD degree 1968 and PhD 1991, University of Barcelona. Educational Council for Foreign Medical Graduates (ECFMG) certification, Barcelona 1970. Postgraduate training in USA (1970-1976): Brooklyn Jewish Hospital, New York, NY; Veterans Administration Hospital and Boston University Medical Center, Boston, MA. American Board of Internal Medicine and American Board of Internal Medicine, subspecialty Gastroenterology, Boston 1973-75. Professional activities Member, founder and ancient vicepresident of the Spanish Atherosclerosis Society (SEA). Member of the European Atherosclerosis Society (EAS) and International Atherosclerosis Society. Ancient President, of the Sociedad Iberolatinoamericana de Aterosclerosis (SILAT). Co-president 74th Congress of the EAS 2004 and president of the Scientific Committee. Member of the Scientific Committee of several EAS congresses. Founder and ancient editor of Clínica e Investigación en Arteriosclerosis, official journal of SEA. Former First editor, British Journal of Nutrition. Member of the Editorial Boards, Metabolism and Nutrients, Advisory Boards: California Walnut Commission, Fundación FLORA (Unilever), Pfizer, Merck, Roche, Amgen, Sanofi, Alexion. Award to best scientific career in Nutrition, Fundación Danone 2013. Grande-Covián Award for a life career in Nutrition, SEA 2014. Golden Nut Award, International Nut Council 2014. Dr. Ros has received numerous research grants from public and private agencies. He has published more than 350 original papers, over 125 reviews papers, 25 editorials, and 87 scientific textbook chapters. He has been a speaker at many scientific conferences and professor at many postgraduate courses in the fields of nutrition, lipid metabolism, atherosclerosis, and cardiac prevention. He has a 30-year experience in clinical trials with antiatherosclerotic diets, foods, and drugs. Actual research interests include nutrition for treatment of cardiovascular risk factors and prevention of chronic diseases, including cardiovascular disease and dementia, plant sterols, blood membrane fatty acids, genetic dyslipidemias, cardiovascular risk assessment and vascular imaging techniques. He also led the nutritional intervention of the landmark PREDIMED trial of Mediterranean diet for primary cardiovascular prevention.